Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
11,547 total articles
ServiceTitan's 2026 industry report highlights a surge in AI adoption among commercial contractors, with 38% now seeing measurable business impact, up from 17% in 2025. Contractors face strong demand but rising labor and material costs, prompting a greater emphasis on profitability, cash flow management, and technology consolidation to improve oper…
Silvaco Group, Inc. announced an expanded strategic partnership with Advanced Power Electronics Corp. (APEC) to leverage Silvaco’s advanced simulation tools including Victory Device, Gateway, and SmartSpice. This collaboration aims to accelerate the development and optimization of APEC’s silicon carbide power devices, impacting industries such as a…
Nanobiotix announced the presentation of early Phase 2 clinical trial results from the Johnson & Johnson-sponsored CONVERGE study evaluating the novel nanoradioenhancer JNJ-1900 (NBTXR3) in patients with stage 3 inoperable non-small cell lung cancer. Initial data demonstrate a favorable safety profile and encouraging efficacy signals, including a h…
Uniti Fiber announced the hiring of Heather Orrico as president of Enterprise Sales to enhance its enterprise sales strategy and drive growth in the Southeastern United States. With over 20 years of telecom experience and proven leadership at Comcast, Orrico's expertise is expected to strengthen Uniti Fiber's position in delivering fiber infrastruc…
BiomX Inc. appointed Dr. Ehud Levi, former Deputy Director of Mossad, to its Advisory Board to support strategic expansion into security, defense, aerial response, and counter-UAS technologies. Dr. Levi's extensive intelligence and counter-terrorism experience is expected to guide BiomX in exploring new partnerships and business opportunities in de…
AleAnna, Inc. announced its financial and operational results for Q4 and full year 2025, reporting a net income of $2.9 million and adjusted EBITDA of $6.6 million for the year. The company achieved strong production performance at its Longanesi field, which exceeded expectations and generated $9.1 million in revenue in Q4. AleAnna also secured the…
Siebert Financial Corp. announced its 2025 financial results, showing a 12% revenue increase driven by a 51% rise in stock loan revenue and growth in retail customer net worth. However, operating income declined due to significant investments in new business lines and technology. The company expanded into collegiate athlete NIL negotiation services…
AirJoule Technologies Corporation announced its Q4 and full year 2025 results, highlighting successful technology validation, product development, strategic partnerships with industry leaders and defense, and strengthened financial position. The company confirmed progress in field deployments across multiple geographies and outlined plans to launch…
Allbirds, Inc. announced a definitive agreement to sell its intellectual property and certain assets to American Exchange Group for approximately $39 million. The sale, pending stockholder approval, will lead to the company's dissolution and winding down, with expected closure in Q2 2026 and distribution of net proceeds to shareholders in Q3 2026. …
Caliber announced that an institutional investor converted $15.9 million of perpetual convertible preferred equity into common stock, reducing senior capital and simplifying its capital structure. This transaction enhances the company's financial flexibility and aligns interests with common shareholders. Caliber is a Nasdaq-listed real estate and d…
Intercont (Cayman) Limited will implement a 25-for-1 reverse share split effective April 2, 2026 to comply with Nasdaq's minimum $1.00 bid price requirement. The company aims to maintain its listing on the Nasdaq Capital Market under ticker symbol NCT, with adjusted shares and a new CUSIP number. The reverse split reduces total authorized shares, a…
JD.com, Inc., a leading supply chain-based technology and service provider, announced its plan to offer CNY-denominated senior unsecured notes in offshore transactions targeting non-U.S. persons. The proceeds from this offering will be used for general corporate purposes including repayment of existing indebtedness. The notes offering is subject to…
StoneX Group Inc. has formed a strategic partnership with The Pathfinder Group to integrate StoneX's institutional-grade cross-border payment infrastructure with Pathfinder's WITS™ platform. This collaboration aims to provide financial institutions, including community banks and credit unions, with access to improved global payment capabilities, be…
IperionX Limited has reported recent changes in the ownership stakes of its directors and officers, filing the information with both the U.S. Securities and Exchange Commission and the Australian Securities Exchange. Key executives, including the CEO and President, have acquired additional shares and American Depositary Shares, reflecting internal …
KANZHUN LIMITED, known as BOSS Zhipin, announced it has repurchased over RMB540 million worth of shares so far in 2026, including a recent purchase of RMB34.5 million on March 27. This substantial share repurchase program highlights the company's commitment to enhancing shareholder value.
Autozi Internet Technology (Global) Ltd. announced that it received a notification from Nasdaq for failing to meet the minimum Market Value of Listed Securities of $50 million over the past 30 consecutive business days. The company has until September 21, 2026, to regain compliance or face potential delisting. The notification does not impact curre…
MoonLake Immunotherapeutics reported Week 40 results from its Phase 3 VELA clinical trials evaluating sonelokimab in adults with moderate-to-severe hidradenitis suppurativa (HS). The data demonstrated continued improvement with 62% of patients achieving HiSCR75 and up to 32% achieving HiSCR100 responses, alongside significant quality of life enhanc…
Kymera Therapeutics announced positive results from its BroADen Phase 1b trial of KT-621, a novel oral STAT6 degrader, in patients with moderate-to-severe atopic dermatitis. The data showed significant biological and clinical improvements with a favorable safety profile. Ongoing Phase 2b trials in atopic dermatitis and asthma are expected to provid…
Arcutis Biotherapeutics announced new positive Phase 2 results from the INTEGUMENT-INFANT trial showing that ZORYVE (roflumilast) cream 0.05% is effective and well tolerated in infants aged 3 months to less than 24 months with mild to moderate atopic dermatitis. Caregivers reported rapid itch improvement and multiple clinical endpoints demonstrated…
Osisko Development Corp. announced its financial and operational results for Q4 and full-year 2025, highlighting approximately CAD 422.3 million in cash, sales of nearly 4,000 ounces of gold from small-scale activities at the Tintic Project, and significant advancement in the Cariboo Gold Project's infill drilling and pre-construction activities. T…
Rocket Lab successfully launched its 85th mission, marking the first dedicated launch for the European Space Agency (ESA) using its Electron launch vehicle. The 'Daughter Of The Stars' mission delivered ESA's Celeste satellites to low Earth orbit to demonstrate enhanced satellite navigation alongside Europe's Galileo constellation. This success und…
Alumis Inc. reported positive Phase 3 results for envudeucitinib, its oral TYK2 inhibitor, demonstrating robust skin clearance, rapid improvements in quality of life and itch relief, and a favorable safety profile in patients with moderate-to-severe plaque psoriasis. Data from two pivotal trials ONWARD1 and ONWARD2 indicate sustained efficacy throu…
Priovant Therapeutics, a Roivant company, reported positive Phase 3 trial results for brepocitinib in dermatomyositis, showing statistically significant improvements over placebo in multiple efficacy endpoints including muscle strength, skin disease, physical function, and corticosteroid reduction. Results were published in the New England Journal …
Biogen announced positive Phase 2 results from the AMETHYST study for litifilimab, an investigational monoclonal antibody targeting BDCA2, demonstrating statistically significant improvement in skin disease activity in patients with cutaneous lupus erythematosus (CLE). These consistent positive results, along with a favorable safety profile and FDA…
Fusion Fuel Green PLC announced details on its anticipated 2% Net Smelter Return (NSR) royalty on two mineral claims within the Shea Creek Joint Venture, part of a 16-uranium-royalty portfolio expected to be acquired through its pending transaction with Royal Uranium Inc. The Shea Creek project hosts significant undeveloped uranium resources in Can…
